reverse T3
Showing 1 - 25 of >10,000
Osteoarthritis of the Shoulder Trial in Canada (Total Shoulder Arthroplasty, Reverse Shoulder Arthroplasty)
Recruiting
- Osteoarthritis of the Shoulder
- Total Shoulder Arthroplasty
- Reverse Shoulder Arthroplasty
-
Edmonton, Alberta, Canada
- +3 more
Jul 1, 2022
Shoulder Osteoarthritis Trial in Edmonton, St. Albert, Ottawa (Reverse Total Shoulder Arthroplasty (RTSA), Total Shoulder
Recruiting
- Shoulder Osteoarthritis
- Reverse Total Shoulder Arthroplasty (RTSA)
- Total Shoulder Arthroplasty (TSA)
-
Edmonton, Alberta, Canada
- +7 more
Jul 14, 2022
TESS V3 Modular Total Shoulder System PMCF
Recruiting
- Osteoarthritis Shoulder
- +9 more
- Anatomic TESS V3
- Reverse TESS V3
-
Lyon, France
- +1 more
Dec 14, 2022
Coronary Artery Disease, Coronary Stenosis, Coronary Bifurcation Disease Trial in Italy (Percutaneous Coronary Intervention)
Not yet recruiting
- Coronary Artery Disease
- +5 more
- Percutaneous Coronary Intervention
-
Ciriè, Tori O, Italy
- +4 more
Mar 22, 2023
Chronic Hepatitis B Trial in Guangzhou (NrtIs, HH-003, HH-003+NrtIs)
Active, not recruiting
- Chronic Hepatitis B
- NrtIs
- +2 more
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Apr 20, 2023
Aicardi-Goutières Syndrome Trial in Edinburgh (Abacavir (ABC), Lamivudine (3TC), Abacavir (ABC)+Lamivudine (3TC)+Zidovudine
Recruiting
- Aicardi-Goutières Syndrome
- Abacavir (ABC)
- +2 more
-
Edinburgh, United KingdomYanick Crow
Aug 26, 2022
Serum rT3 Concentrations, T3/T4 Ratio, and Symptoms/Quality of
Recruiting
- Hypothyroidism
- Quality of life assessment, biochemical measures
-
Budapest, HungarySemmelweis University - Departement Medicine and Oncology
Sep 21, 2021
Degenerative Joint Disease, Osteoarthritis, Hip, Avascular Necrosis of Hip Trial (Hip Innovation Technology Reverse Hip
Recruiting
- Degenerative Joint Disease
- +3 more
- Hip Innovation Technology Reverse Hip Replacement System
- Already-marketed semi-constrained uncemented hip systems using a metal-on-XLPE or ceramic-on-XLPE bearing combination.
-
Somers Point, New JerseyDivision of Orthopaedic Surgery
Jan 16, 2023
Trabecular Metal (TM) Reverse Shoulder System
Active, not recruiting
- Osteoarthritis
- +7 more
- Trabecular Metal Reverse Shoulder System
-
San Francisco, California
- +4 more
Mar 25, 2022
HIV Trial in Worldwide (Darunavir (DRV) 800 milligram (MG) Oral Tablet, Ritonavir 100 MG Oral Tablet, N(t)RTIs)
Recruiting
- HIV Infections
- Darunavir (DRV) 800 milligram (MG) Oral Tablet
- +6 more
-
Chennai, India
- +6 more
Aug 30, 2021
Primary Palmar Hyperhydrosis Trial in Cairo (Endoscopic thoracic T3 sympathectomy, ThoracicT3 radiofrequency ablation)
Not yet recruiting
- Primary Palmar Hyperhydrosis
- Endoscopic thoracic T3 sympathectomy
- ThoracicT3 radiofrequency ablation
-
Cairo, EgyptAin shams university
Feb 17, 2023
Atrial Fibrillation, Overweight and Obesity Trial in Bath (Super Rehab)
Not yet recruiting
- Atrial Fibrillation
- Overweight and Obesity
- Super Rehab
-
Bath, United KingdomRoyal United Hospitals Bath NHS Foundation Trust
Oct 26, 2022
Cholesterol, HDL, Lipid Metabolism, Inborn Errors, Tangier Disease Trial in Philadelphia (3H-cholesterol bound to albumin)
Suspended
- Cholesterol, HDL
- +4 more
- 3H-cholesterol bound to albumin
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jul 14, 2022
Stage T3 Squamous Cell Carcinomas of the Scalp
Active, not recruiting
- Squamous Cell Carcinoma
- +2 more
-
Maastricht, NetherlandsEllen Oyen
Aug 3, 2023
Chronic Hepatitis B Trial in Hong Kong, Auckland (VRON-0200-AdC6, VRON-0200-AdC7)
Recruiting
- Chronic Hepatitis B
- VRON-0200-AdC6
- VRON-0200-AdC7
-
Hong Kong, Hong Kong
- +1 more
Oct 6, 2023
Stellate Ganglion, Radiofrequency Ablation, Complex Regional Pain Syndromes Trial in Cairo (Radiofrequency stellate ganglion
Not yet recruiting
- Stellate Ganglion
- +3 more
- Radiofrequency stellate ganglion block using ultrasound guidance (SGB)
- +2 more
-
Cairo, EgyptNational Cancer Institute
Sep 5, 2023
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Germany (Cyclophosphamide (Non-IMP,
Not yet recruiting
- Acute Myeloid Leukemia, in Relapse
- Acute Myeloid Leukemia Refractory
- Cyclophosphamide (Non-IMP, Lymphodepletion)
- +3 more
-
Ulm, Baden-Württemberg, Germany
- +4 more
Jul 24, 2023
Fibula / Surgery, Surgical Flaps, Computer-Aided Design Trial in Cairo (Computer guided placement of a stock plate pre-bent on a
Recruiting
- Fibula / Surgery
- +4 more
- Computer guided placement of a stock plate pre-bent on a 3D printed model
-
Cairo, EgyptCairo University - Faculty of Oral and Dental Medicine
Jan 3, 2023
Dentofacial Deformities Trial in Giza (Maxillary Segment Repositioning)
Recruiting
- Dentofacial Deformities
- Maxillary Segment Repositioning
-
Giza, EgyptFaculty of Dentistry, Cairo University
Feb 23, 2023
Peripheral Artery Disease (PAD) Trial (Stent PULSAR® -18 T3,)
Not yet recruiting
- Peripheral Artery Disease (PAD)
- Stent PULSAR® -18 T3,
- (no location specified)
Dec 26, 2022
Heart Failure Trial in Atlanta (Thyroid hormone T3, Control Group)
Recruiting
- Heart Failure
- Thyroid hormone T3
- Control Group
-
Atlanta, Georgia
- +1 more
Nov 14, 2022
Rectal Cancer Trial (Neoadjuvant Chemoradiotherapy, Total Neoadjuvant Therapy)
Not yet recruiting
- Rectal Cancer
- Neoadjuvant Chemoradiotherapy
- Total Neoadjuvant Therapy
- (no location specified)
Oct 24, 2023
Covid19, SARS-CoV Infection, ARDS Trial in Minneapolis (Instilled T3, Placebo Therapy)
Recruiting
- Covid19
- +3 more
- Instilled T3
- Placebo Therapy
-
Minneapolis, MinnesotaUniversity of Minnesota
Sep 1, 2022
Colorectal Cancer, Chemo Effect Trial in GuangZhou (FOLFOX chemo regimens, Bevacizumab)
Not yet recruiting
- Colorectal Cancer
- Chemotherapy Effect
- FOLFOX chemotherapy regimens
- Bevacizumab
-
GuangZhou, Guangdong, ChinaThe Sixth Affiliate Hospital of Sun Yat-Sen University
Apr 3, 2023